Scripps Research Institute: Developing a Vaccine for the "Zombie Drug" Xylazine
April 04, 2024
April 04, 2024
LA JOLLA, California, April 4 (TNSres) -- The Scripps Research Institute issued the following news:
* * *
Scripps Research chemical biologists design an early "proof-of-concept" vaccine that could lead to the first effective treatment of xylazine overdose in people.
* * *
Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to . . .
* * *
Scripps Research chemical biologists design an early "proof-of-concept" vaccine that could lead to the first effective treatment of xylazine overdose in people.
* * *
Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to . . .